Patients with Glioblastoma (GBM), a highly aggressive malignant brain tumor, have an extremely poor prognosis due to a lack of viable treatment choices. Since being named the “breakthrough of the year ...

Immuno-PET imaging is an advanced molecular diagnostic technique that merges the high sensitivity of positron emission tomography with the exquisite target specificity of monoclonal antibodies. By ...

A novel immuno-PET/CT imaging technique has identified and validated a potent biomarker for nasopharyngeal cancer (NPC). The biomarker, CD70, is highly and constantly expressed in NPCs, and ...

Representative PET images of 89 ZrDFO-trastuzumab displaying %ID/g acquired 48 hours after radiolabeled trastuzumab injection on day 39 for T-DM1 single-treatment regime, T-DM1/statin single-treatment ...

Clear cell renal cell carcinoma (RCC) comprises 80% of all primary kidney malignancies and causes 90% of kidney cancer deaths. But it is notoriously tough to diagnose. RCC is not easily distinguished ...

IL12/23p40 immuno-PET/CT imaging of healthy and DSS-treated mice. Representative maximum-intensity projection images of healthy (left) and DSS-treated (right) mice acquired at 24 hours (day 6) and 48 ...

SUZHOU, China, March 3, 2023 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, ...

A new molecular imaging agent can accurately identify a crucial biomarker found among many different types of cancer. Precise visualization of the trophoblast cell surface antigen 2 (Trop2) biomarker ...

Positron emission tomography (PET) is an imaging modality to better understand the pathophysiology of a disease at molecular level and typically referred to as molecular imaging. It reveals the ...